Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Hartmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the Medical Association of Georgia|April 1, 1976
The role of specialty societies in continuing educationH R Hartmann
Journal of the National Cancer Institute|March 1, 1980
Requirement of RNA and protein synthesis and inhibition by ethylenediaminetetraacetic acid of retinoic acid-induced proteoglycan release in a transplantable rat chondrosarcomaA Kistler, H R Hartmann
Oncology|January 1, 1983
Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing miceJ Kreuter, H R Hartmann
Cancer Research|June 1, 1982
Antiproliferative action of a novel fluorinated uridine analog, 5'-deoxy-5-fluorouridine, measured in vitro and in vivo on four different murine tumor linesH R Hartmann, A Matter
Advances in Experimental Medicine and Biology|January 1, 1984
Tumor specific conversion of a pyrimidine antimetaboliteH R Hartmann, W Bollag
AJR. American Journal of Roentgenology|June 1, 1989
Simple method to identify sequential imagesR Dalal, H R Hartmann
European Journal of Cancer & Clinical Oncology|February 1, 1987
Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778)W Bollag, H R Hartmann
Schweizerische Medizinische Wochenschrift|July 8, 1980
[5'-deoxy-5-fluoruridine, a new antineoplastic pyrimidine antimetabolite]H R Hartmann, W Bollag
Cancer Chemotherapy and Pharmacology|January 1, 1985
The effects of arotinoids on rat mammary carcinogenesisH R Hartmann, W Bollag
European Journal of Cancer|April 1, 1980
Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridineW Bollag, H R Hartmann
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the Medical Association of Georgia|April 1, 1976
The role of specialty societies in continuing educationH R Hartmann
Journal of the National Cancer Institute|March 1, 1980
Requirement of RNA and protein synthesis and inhibition by ethylenediaminetetraacetic acid of retinoic acid-induced proteoglycan release in a transplantable rat chondrosarcomaA Kistler, H R Hartmann
Oncology|January 1, 1983
Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing miceJ Kreuter, H R Hartmann
Cancer Research|June 1, 1982
Antiproliferative action of a novel fluorinated uridine analog, 5'-deoxy-5-fluorouridine, measured in vitro and in vivo on four different murine tumor linesH R Hartmann, A Matter
Advances in Experimental Medicine and Biology|January 1, 1984
Tumor specific conversion of a pyrimidine antimetaboliteH R Hartmann, W Bollag
AJR. American Journal of Roentgenology|June 1, 1989
Simple method to identify sequential imagesR Dalal, H R Hartmann
European Journal of Cancer & Clinical Oncology|February 1, 1987
Inhibition of rat mammary carcinogenesis by an arotinoid without a polar end group (Ro 15-0778)W Bollag, H R Hartmann
Schweizerische Medizinische Wochenschrift|July 8, 1980
[5'-deoxy-5-fluoruridine, a new antineoplastic pyrimidine antimetabolite]H R Hartmann, W Bollag
Cancer Chemotherapy and Pharmacology|January 1, 1985
The effects of arotinoids on rat mammary carcinogenesisH R Hartmann, W Bollag
European Journal of Cancer|April 1, 1980
Tumor inhibitory effects of a new fluorouracil derivative: 5'-deoxy-5-fluorouridineW Bollag, H R Hartmann
Pageof 2